Atlas Capital Advisors
Atlas Capital Advisors reported 1,049 stocks worth $914M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are VGK (4.8%), XLK (2.5%) and EMXC (2.2%). Compared with Q1 2026, the fund added to VGK, XLK and EMXC, trimmed VPL, AAPL and FTEC and sold out of PLMR, REGN and ARHS.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 7 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  VGK Vanguard Ftse Europe | $43.4M | 4.8% | 490K | +19K (+4%) | 7 of 7 | |
| 2 |  XLK Select Sector Spdr TR | $23M | 2.5% | 121K | +5,318 (+5%) | 7 of 7 | |
| 3 |  EMXC Ishares Msci Emerging Markets EX China ETF | $20.1M | 2.2% | 197K | +15K (+9%) | 7 of 7 | |
| 4 |  SPEM Spdr Emerging | $18.9M | 2.1% | 366K | +8,513 (+2%) | 7 of 7 | |
| 5 |  IMTM Ishares TR | $17.3M | 1.9% | 324K | +68K (+26%) | 7 of 7 | |
| 6 |  VPL Vanguard Ftse Pacific ETF | $12.7M | 1.4% | 110K | −1,330 (−1%) | 7 of 7 | |
| 7 |  VOE Vanguard Index Fds | $12.6M | 1.4% | 64K | +6,666 (+12%) | 7 of 7 | |
| 8 |  AAPL Apple Inc | $12.2M | 1.3% | 42K | −25K (−37%) | 7 of 7 | |
| 9 |  FTEC Fidelity Covington Trust | $12.1M | 1.3% | 42K | −960 (−2%) | 7 of 7 | |
| 10 |  BBAX J P Morgan Exchange Traded F | $12M | 1.3% | 200K | +15K (+8%) | 7 of 7 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 PLMR Palomar Hldgs Inc | $21.7M | 182K |
 REGN Regeneron Pharmaceutical | $6M | 7,758 |
 ARHS Arhaus Inc | $1.5M | 224K |
 BBH Vaneck Biotech ETF | $1M | 5,450 |
AIR LEASE CORP | $519K | 7,989 |
🔒 Free account: see all 30.
Reported value
last 7 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR/A Amendment | Q2 2026 | SEC filing ↗ |
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Includes an amendment, which can add positions the fund kept confidential at first, or replace the original report.
Other superinvestors
All hedge fund holdings →Atlas Capital Advisors 13F FAQ
What does Atlas Capital Advisors own?
Atlas Capital Advisors reported 1,049 stocks worth $914M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are VGK (4.8%), XLK (2.5%) and EMXC (2.2%). The table above lists every position in the filing (the top 10 without an account).
What did Atlas Capital Advisors buy and sell in Q2 2026?
Compared with Q1 2026: 137 new positions, 352 added to, 244 trimmed and 76 sold out. It sold all of PLMR, REGN and ARHS.
When will Atlas Capital Advisors file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Atlas Capital Advisors's portfolio worth?
The Q2 2026 filing reports $914M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.